No abstract available.
Diagnosis* ; Echocardiography*

Traumatic dislocation of the knee joint occurs very infrequently, but is one of the true emergencies in the orthopedic field. It is a serious injury, associated with extensive soft tissue demage and the danger of neurological and vascular involvement. There is a lot of theories about the mechanism of injury, the treatment and the incidence of complications. Generally they accept that in irreducible cases operative reduction is essential, but there is no uniformity of opinion on the treatment of the uncomplicated cases. This paper is based on 7 traumatic knee dislocations treated at Kang Nam Sacred Heart Hospital, Hallym College during the period from January 1980 till December 1984. The results of the study are as follows: 1. The patients are mostly injured due to the traffic accident and show even age distribution from twenties to fifties. 2. 5 cases out of 7, reduced at our hospital, were all anteriorly dislocated. 3. The posterior capsule and the posterior cruciate ligament were injured in all cases. 4. There were no significant differences between primary repair of soft tissues and the late reconstruction.
Accidents, Traffic ; Age Distribution ; Clinical Study ; Clothing ; Dislocations ; Emergencies ; Heart ; Humans ; Incidence ; Knee Dislocation ; Knee Joint ; Knee ; Orthopedics ; Posterior Cruciate Ligament

No Abstract Available.
Receptors, Cytoplasmic and Nuclear*

No abstract available.
Enzyme-Linked Immunosorbent Assay*

No abstract available.
Enzyme-Linked Immunosorbent Assay*

No abstract available.
Enzyme-Linked Immunosorbent Assay*

No abstract available.
Anti-Ulcer Agents/*therapeutic use ; Chromogranin A/*blood ; Combined Modality Therapy ; Gastrins/*blood ; Ghrelin/*blood ; Histamine H2 Antagonists/*therapeutic use ; Humans ; Proton Pump Inhibitors/*therapeutic use

No abstract available.
Carcinoid Tumor/etiology/*pathology ; Disease Progression ; Gastrointestinal Neoplasms/etiology/*pathology ; Humans ; Ki-67 Antigen/analysis ; Neoplasm Metastasis ; Predictive Value of Tests

No abstract available.
Carcinoid Tumor* ; Rectum*

Antiplatelet therapies have been widely used to prevent cardiovascular diseases. However, antiplatelet agents cause gastrointestinal (GI) damage and are associated with a greater risk of gastroduodenal ulcers and life-threatening ulcer complications. The first step to reduce the GI risk of antiplatelet therapy is to assess whether the patient requires continuous antiplatelet therapy. The second step is to eliminate risk factors that may place the patient at greater GI risk such as Helicobacter pylori infection, NSAID use, steroid ingestion, and smoking. Continuous aspirin therapy plus a powerful proton pump inhibitor (PPI) is the choice of treatment for antiplatelet-related peptic ulcers. The risk of cardiovascular complications and risk of gastric complication using antiplatelet agents should be evaluated individually.
Aspirin ; Cardiovascular Diseases ; Eating ; Helicobacter pylori ; Humans ; Peptic Ulcer* ; Platelet Aggregation Inhibitors ; Proton Pumps ; Risk Factors ; Smoke ; Smoking ; Ulcer